Skip to main content
  • Dec 05, 2019

    Check and Point to Side Effects

    Uveitis, Cornea/External Disease
    Case CME
    1 Self-Assessment AMA PRA Category 1 Credits™

    A patient presents with symptoms of progressive, bilateral blurred vision 2 weeks following a second infusion of nivolumab as monotherapy for metastatic, BRAF-positive malignant melanoma. The goal of this case is to improve knowledge of antitumor therapies.